Toward the institutionalization of quantum computing in pharmaceutical research
Related Experiment Video
Updated: Oct 15, 2025

Large Scale Energy Efficient Sensor Network Routing Using a Quantum Processor Unit
Published on: September 8, 2023
Maximillian Zinner1, Florian Dahlhausen1, Philip Boehme2
1Didactics and Educational Research in Health Care, Faculty of Health, School of Medicine, Witten/Herdecke University, Germany.
Abstract:
Innovative pharmaceutical companies have started to explore quantum computing (QC). In this article, we provide a collective industry perspective from QC domain leaders at leading pharmaceutical companies. There are immediate nonfinancial benefits in engaging with QC, some likely financial returns in the short term in drug development, manufacturing, and supply chain, and potentially large scientific benefits in drug discovery long term. We discuss the required activities for institutionalizing QC: how to create an understanding of QC among researchers and management, which and how to deploy external resources, and how to identify the problems to be addressed with QC. If (and once) deployable, QC will likely have a similar trajectory to that of computer-aided drug design (CADD) and artificial intelligence (AI) during the 1990s and 2010s, respectively.
More Related Videos
05:39Scalable Quantum Integrated Circuits on Superconducting Two-Dimensional Electron Gas Platform
Published on: August 2, 2019
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
The Quantum-Mechanical Model of an Atom
Quantitative Aspects of Drug-Receptor Interaction
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...